MedTwenty
Companies

Foundation Medicine

This profile is still being built. It is not yet listed in the company index.

MedTwenty Indices and trackers are editorial indicators and business information. They are not investment, financial, legal or medical advice, and not a regulated benchmark.

Summary

Comprehensive genomic profiling provider owned by Roche, and the principal competitor for NHS pathology network contracts.

Finances

Not published (small company accounts)

Timeline

No verified timeline entries yet.

MedTwenty coverage